chr20-483965-T-A
Variant names:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_177559.3(CSNK2A1):c.1172A>T(p.Gln391Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Consequence
CSNK2A1
NM_177559.3 missense
NM_177559.3 missense
Scores
3
4
12
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 5.28
Genes affected
CSNK2A1 (HGNC:2457): (casein kinase 2 alpha 1) Casein kinase II is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythm. The kinase exists as a tetramer and is composed of an alpha, an alpha-prime, and two beta subunits. The alpha subunits contain the catalytic activity while the beta subunits undergo autophosphorylation. The protein encoded by this gene represents the alpha subunit. Multiple transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Apr 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the CSNK2A1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 28 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. Gene score misZ: 3.7123 (above the threshold of 3.09). Trascript score misZ: 5.3205 (above the threshold of 3.09). GenCC associations: The gene is linked to syndromic intellectual disability, Okur-Chung neurodevelopmental syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.1933771).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248938Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134774
GnomAD3 exomes
AF:
AC:
1
AN:
248938
Hom.:
AF XY:
AC XY:
0
AN XY:
134774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
1
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T;T;.;.;T;.;.;.;.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;.;.;.;.;T;.;.;T;.;T;T;T;.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N;.;N;N;.;.;N;.;.;.;.;.;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Pathogenic
.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.
Polyphen
B;B;B;.;B;B;.;.;B;.;.;.;.;.;B;B
Vest4
0.51
MutPred
Gain of stability (P = 0);Gain of stability (P = 0);Gain of stability (P = 0);.;Gain of stability (P = 0);Gain of stability (P = 0);.;.;Gain of stability (P = 0);.;.;.;.;.;Gain of stability (P = 0);Gain of stability (P = 0);
MVP
0.84
MPC
0.065
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at